BioSensics launches its Sensor-Integrated Digital Platform for measurement and remote monitoring of movement-based biomarkers in clinical trials. The platform combines clinical-grade wearable sensors with turnkey data transfer and storage solutions to enable objective and timely collection of sensor and ePRO data from trial participants.
Clinically-validated algorithms enable assessment of a wide range of endpoints from the sensor data including physical activity, falls, gait, balance, frailty, and fatigue, as well as disease-specific motor symptoms such as tremor, chorea, and foot drop. Relevant therapeutic areas include stroke, Alzheimer’s disease, CNS and musculoskeletal disorders, orthopaedics, oncology, and many others.
The platform is driven by the company’s wearable sensors that gather data from participants during activities of daily living, while also alerting the clinical study staff in case of non-compliance in wearing the sensors. The platform includes a customizable ePRO interface via smartphone or tablet and allows for automatic data transfer to a HIPAA compliant cloud server.
In addition to the Sensor-Integrated Digital Platform, BioSensics offers related clinical trial services based on decades of direct experience in clinical research. An expert team of biomechanists, algorithm development scientists, and biomedical engineers provide hands-on support services at every stage of the trial. Services include scientific consulting, custom algorithms and analytics, data management and reporting, patient follow-up, site-training, and technical support.
For more details, peruse the Sensor-Integrated Digital Platform page and/or call BioSensics at 888-589-6213.